We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Aisling Capital Management
New York
$3.2M
QUSVM
2
Qiming U.S. Ventures Management
Washington
$2.68M
BI
3
BVF Inc
California
$2.61M
CAM
4
Cormorant Asset Management
Massachusetts
$2.21M -$39.2K -31,136 -2%
VP
5
venBio Partners
California
$2.11M
SB
6
Samsara BioCapital
California
$939K
TCM
7
TCG Crossover Management
California
$627K
SCM
8
Sio Capital Management
New York
$406K
Vanguard Group
9
Vanguard Group
Pennsylvania
$376K -$85.4K -67,829 -17%
Renaissance Technologies
10
Renaissance Technologies
New York
$326K +$38.1K +30,257 +12%
KCM
11
Kennedy Capital Management
Missouri
$169K -$307 -244 -0.2%
BCM
12
Bridgeway Capital Management
Texas
$152K -$27.7K -22,000 -14%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$102K +$81K +64,361 +245%
CC
14
Caxton Corporation
New Jersey
$77K +$5 +4 +0%
MAM
15
Marquette Asset Management
Minnesota
$44K
BlackRock
16
BlackRock
New York
$42K -$1.06K -845 -2%
AC
17
Annandale Capital
Texas
$34K +$37.8K +30,000 New
State Street
18
State Street
Massachusetts
$21K
TRCT
19
Tower Research Capital (TRC)
New York
$8K +$2K +1,585 +29%
Osaic Holdings
20
Osaic Holdings
Arizona
$1K
SPIA
21
Steward Partners Investment Advisory
New York
$1K
BC
22
Boxer Capital
California
-$1.22M -872,780 Closed
Janus Henderson Group
23
Janus Henderson Group
-$250K -179,080 Closed
VF
24
Virtu Financial
New York
-$31K -21,798 Closed
Millennium Management
25
Millennium Management
New York
-$30K -21,573 Closed